Apeikon Therapeutics is a startup based in the United Kingdom, 1 tracked investor.
Apeikon Therapeutics is a startup based in the United Kingdom. Brouky records 1 investor associated with the company.
Apeikon Therapeutics is a UK-based biotechnology company developing novel therapeutics for neurodegenerative diseases such as Alzheimer's and Parkinson's. They leverage a proprietary platform focused on neuroinflammation and mitochondrial dysfunction to identify drug candidates.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.